Cargando…
Mass Spectrometry-Based Multivariate Proteomic Tests for Prediction of Outcomes on Immune Checkpoint Blockade Therapy: The Modern Analytical Approach
The remarkable success of immune checkpoint inhibitors (ICIs) has given hope of cure for some patients with advanced cancer; however, the fraction of responding patients is 15–35%, depending on tumor type, and the proportion of durable responses is even smaller. Identification of biomarkers with str...
Autores principales: | Grigorieva, Julia, Asmellash, Senait, Net, Lelia, Tsypin, Maxim, Roder, Heinrich, Roder, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036840/ https://www.ncbi.nlm.nih.gov/pubmed/32012941 http://dx.doi.org/10.3390/ijms21030838 |
Ejemplares similares
-
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
por: Ascierto, Paolo A., et al.
Publicado: (2019) -
A proposal for score assignment to characterize biological processes from mass spectral analysis of serum
por: Roder, Joanna, et al.
Publicado: (2020) -
Extending the information content of the MALDI analysis of biological fluids via multi-million shot analysis
por: Tsypin, Maxim, et al.
Publicado: (2019) -
A dropout-regularized classifier development approach optimized for precision medicine test discovery from omics data
por: Roder, Joanna, et al.
Publicado: (2019) -
Robust identification of molecular phenotypes using semi-supervised learning
por: Roder, Heinrich, et al.
Publicado: (2019)